At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
Restylane Volyme +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study Comparing Hyaluronic Acid Effectiveness & Evaluating Cheek Results With Restylane
In Brief
A clinical study evaluating Restylane Volyme and Restylane Lyft Lidocaine for Cheek Augmentation. Completed, enrolled 60 participants across 3 sites.
Detailed Summary
Open-label, phase IV, post-marketing study to evaluate aesthetic improvement and satisfaction after treatment with Restylane
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCheek Augmentation
CountriesCanada
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedNov 2020
Enrollment StartApr 2021
Primary CompletionJul 2021
Study CompletionAug 2021
TodayJul 2026
First PostedNov 20, 2020
Enrollment StartApr 16, 2021
Primary CompletionJul 3, 2021
Study CompletionAug 20, 2021
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 5.6 years ago
Interventions
Restylane Volymedevice
Hyaluronic Acid: Injectable gel for contouring effect (of cheek volumization).
Restylane Lyft Lidocainedevice
Hyaluronic Acid: Injectable gel for projection effect (of cheek augmentation).